APOLLO HOSPITALS ENTER. L vs GLENMARK PHARMACEUTICALS
A side-by-side comparison of APOLLO HOSPITALS ENTER. L (APOLLOHOSP) and GLENMARK PHARMACEUTICALS (GLENMARK) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.
APOLLO HOSPITALS ENTER. L vs GLENMARK PHARMACEUTICALS are evenly matched on the numbers (7–7). The breakdown below shows where each one wins.
- Valuation22
- Profitability13
- Growth11
- Size & financial health31
Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.
Valuation
EvenHow expensive each stock is relative to its earnings and book value. Lower usually means cheaper.
Profitability
GLENMARK takes 3/4How efficiently each company turns capital and sales into profit. Higher is better.
Growth
EvenThree-year compounded growth. Faster-growing businesses can justify a higher valuation.
Size & financial health
APOLLOHOSP takes 3/4Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.
- + ["Company has delivered good profit growth of 71.0% CAGR over last 5 years", "Company has delivered good sales growth of 19.0% CAGR over last 5 years"]
- − ["Stock is trading at 11.97 times its book value"]
- + ["Company is almost debt free."]
- − ["Stock is trading at 5.98 times its book value", "The company has delivered a poor sales growth of 9.2% over past five years.", "Company has a low return on equity of 3.4% over last 3 years."]
This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.